The latest information from ACC in New Orleans March 24-27, 2007 contradicts our common practice wisdom that percutaneous intervention (PCI) + medical therapy is superior compared optimal medical terapy (OMT) alone in patients with chronic stable angina (CSA). CSA patients typically have a regular and predictable chest pains on exertion that resolves with rest.
The latest data we have on the COURAGE trial showed that the use of PCI + OMT did not afford any additional reduction in cardiovascular mortality as compared to OMT alone.
This information should not be construed as if PCI is absolutely not needed in CSA patient because this may still be employed if patients persist to have chest pains inspite of optimal medical therapy.
Furthermore this latest medical update should not be confused with the scientific proofs we have regarding the benefit of PCI in patients suffering an acute myocardial infarction or "heart attack". The benefit on intervention in acute myocardial infarction remains undisputed to date.
